209 related articles for article (PubMed ID: 24990932)
1. Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.
Belaid H; Adrien J; Laffrat E; Tandé D; Karachi C; Grabli D; Arnulf I; Clark SD; Drouot X; Hirsch EC; François C
J Neurosci; 2014 Jul; 34(27):9124-33. PubMed ID: 24990932
[TBL] [Abstract][Full Text] [Related]
2. Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems.
Grabli D; Karachi C; Folgoas E; Monfort M; Tande D; Clark S; Civelli O; Hirsch EC; François C
J Neurosci; 2013 Jul; 33(29):11986-93. PubMed ID: 23864685
[TBL] [Abstract][Full Text] [Related]
3. Role of the pedunculopontine nucleus in controlling gait and sleep in normal and parkinsonian monkeys.
Karachi C; Francois C
J Neural Transm (Vienna); 2018 Mar; 125(3):471-483. PubMed ID: 28084536
[TBL] [Abstract][Full Text] [Related]
4. Role of pedunculopontine cholinergic neurons in the vulnerability of nigral dopaminergic neurons in Parkinson's disease.
Bensaid M; Michel PP; Clark SD; Hirsch EC; François C
Exp Neurol; 2016 Jan; 275 Pt 1():209-19. PubMed ID: 26571193
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a role of basal ganglia in the regulation of rapid eye movement sleep by electrical and chemical stimulation for the pedunculopontine tegmental nucleus and the substantia nigra pars reticulata in decerebrate cats.
Takakusaki K; Saitoh K; Harada H; Okumura T; Sakamoto T
Neuroscience; 2004; 124(1):207-20. PubMed ID: 14960352
[TBL] [Abstract][Full Text] [Related]
6. Effect of l-DOPA on local field potential relationship between the pedunculopontine nucleus and primary motor cortex in a rat model of Parkinson's disease.
Geng X; Wang X; Xie J; Zhang X; Wang X; Hou Y; Lei C; Li M; Han H; Yao X; Zhang Q; Wang M
Behav Brain Res; 2016 Dec; 315():1-9. PubMed ID: 27515286
[TBL] [Abstract][Full Text] [Related]
7. A non-cholinergic neuronal loss in the pedunculopontine nucleus of toxin-evoked parkinsonian rats.
Pienaar IS; van de Berg W
Exp Neurol; 2013 Oct; 248():213-23. PubMed ID: 23769975
[TBL] [Abstract][Full Text] [Related]
8. Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease.
Belaid H; Adrien J; Karachi C; Hirsch EC; François C
Sleep Med; 2015 Oct; 16(10):1245-51. PubMed ID: 26429753
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal interaction between monoaminergic systems and the pedunculopontine nucleus: Implication in the mechanism of L-DOPA.
Di Giovanni G; Chagraoui A; Puginier E; Galati S; De Deurwaerdère P
Neurobiol Dis; 2019 Aug; 128():9-18. PubMed ID: 30149181
[TBL] [Abstract][Full Text] [Related]
10. Spike and Local Field Synchronization Between the Pedunculopontine Nucleus and Primary Motor Cortex in a Rat Model of Parkinson's Disease.
Geng X; Wang X; He F; Zhang X; Xie J; Gao G; Han H; Yao X; Zhang H; Gao Y; Wang Y; Wang M
Neuroscience; 2019 Apr; 404():470-483. PubMed ID: 30710670
[TBL] [Abstract][Full Text] [Related]
11. Topography of the sleep/wake states related EEG microstructure and transitions structure differentiates the functionally distinct cholinergic innervation disorders in rat.
Petrovic J; Lazic K; Ciric J; Kalauzi A; Saponjic J
Behav Brain Res; 2013 Nov; 256():108-18. PubMed ID: 23933142
[TBL] [Abstract][Full Text] [Related]
12. Sleep disorders in Parkinson's disease: the contribution of the MPTP non-human primate model.
Barraud Q; Lambrecq V; Forni C; McGuire S; Hill M; Bioulac B; Balzamo E; Bezard E; Tison F; Ghorayeb I
Exp Neurol; 2009 Oct; 219(2):574-82. PubMed ID: 19635479
[TBL] [Abstract][Full Text] [Related]
13. Spike discharge characteristic of the caudal mesencephalic reticular formation and pedunculopontine nucleus in MPTP-induced primate model of Parkinson disease.
Goetz L; Piallat B; Bhattacharjee M; Mathieu H; David O; Chabardès S
Neurobiol Dis; 2019 Aug; 128():40-48. PubMed ID: 30086388
[TBL] [Abstract][Full Text] [Related]
14. D1 receptor agonist improves sleep-wake parameters in experimental parkinsonism.
Hyacinthe C; Barraud Q; Tison F; Bezard E; Ghorayeb I
Neurobiol Dis; 2014 Mar; 63():20-4. PubMed ID: 24211719
[TBL] [Abstract][Full Text] [Related]
15. Hallucinations and sleep disturbances in Parkinson's disease.
Kulisevsky J; Roldan E
Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
[TBL] [Abstract][Full Text] [Related]
16. DREADD Activation of Pedunculopontine Cholinergic Neurons Reverses Motor Deficits and Restores Striatal Dopamine Signaling in Parkinsonian Rats.
Sharma PK; Wells L; Rizzo G; Elson JL; Passchier J; Rabiner EA; Gunn RN; Dexter DT; Pienaar IS
Neurotherapeutics; 2020 Jul; 17(3):1120-1141. PubMed ID: 31965550
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic, Glutamatergic, and GABAergic Neurons of the Pedunculopontine Tegmental Nucleus Have Distinct Effects on Sleep/Wake Behavior in Mice.
Kroeger D; Ferrari LL; Petit G; Mahoney CE; Fuller PM; Arrigoni E; Scammell TE
J Neurosci; 2017 Feb; 37(5):1352-1366. PubMed ID: 28039375
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of istradefylline treatment on Parkinsonian motor and cognitive deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated macaque models.
Ko WKD; Camus SM; Li Q; Yang J; McGuire S; Pioli EY; Bezard E
Neuropharmacology; 2016 Nov; 110(Pt A):48-58. PubMed ID: 27424102
[TBL] [Abstract][Full Text] [Related]
19. Age-related disorders of sleep and motor control in the rat models of functionally distinct cholinergic neuropathology.
Ciric J; Lazic K; Petrovic J; Kalauzi A; Saponjic J
Behav Brain Res; 2016 Mar; 301():273-86. PubMed ID: 26756440
[TBL] [Abstract][Full Text] [Related]
20. [Rapid-eye-movement sleep disorders in Parkinson's disease].
Gagnon JF; Montplaisir J; Bédard MA
Rev Neurol (Paris); 2002 Feb; 158(2):135-52. PubMed ID: 11965170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
